6,206 results match your criteria Archivos espanoles de urologia[Journal]


3D imaging and urology: Why 3D reconstruction will be mandatory before performing surgery.

Arch Esp Urol 2019 04;72(3):347-352

IRCAD. Research Institute against Cancer of the Digestive System. France. IHU-Strasbourg. Institute of Image-Guided Surgery. France.

Objective: We relate a single-center experience in virtual surgical planning to demonstrate interests and perspectives in pediatric urology. METHOD: From 2004 to April 2017, 4 patients were analyzed before intervention at our institution. All patients had undergone a low dose CT scan. Read More

View Article

Download full-text PDF

Source
April 2019
6 Reads

Current status of robotic kidney transplant and its future.

Arch Esp Urol 2019 04;72(3):336-346

Department of Urology. Fundació Puigvert. Autonomous University of Barcelona. Barcelona. Spain.

Objectives: Open kidney transplantation (OKT) represents the standard approach in patients with end-stage renal disease, but recently robotic-assisted kidney transplantation (RAKT) has also become an accepted approach.

Methods: We conducted a systematic review using the PubMed/Medline and Embase databases and the keywords "Robotic kidney transplantation" and "Robotic-assisted kidney transplantation".

Results: Past studies of RAKT have tended to suffer from patient selection bias, but, following completion of the learning curves in specialized centers, the indications for RAKT have recently been expanded to include more complex cases. Read More

View Article

Download full-text PDF

Source
April 2019
1 Read

Role of robotic surgery in functional urology.

Arch Esp Urol 2019 04;72(3):326-335

Hospital Universitario Rey Juan Carlos. Madrid. España.

Three-dimensional, high-definition images, small instruments with endowrist technology, ergonomic position and the easiness to teach, are possibly the main reasons why robotic surgery will continue to gain ground to others forms of surgery. The current applications of robotics in functional urology are: the correction of pelvic organ prolapse, the correction of female stress urinary incontinence (artificial urinary sphincter) and the treatment of chronic pelvic pain (pudendal nerveneurolysis). In this paper, we explain our robotic techniques in these three scenarios, as well as, provide the most updated data of our series. Read More

View Article

Download full-text PDF

Source
April 2019
9 Reads

Intracorporeal orthotopic neobladder formation: Why not to do it?

Arch Esp Urol 2019 04;72(3):318-325

Department of Urology. Mayo Clinic Arizona. Phoenix. Arizona. USA.

Objectives: There has been growing  interest in intracorporeal techniques to urinary diversion during cystectomy in the modern area. There is little high-quality evidence that this technique is superior to  extracorporeal diversion in patients who are obtaining  an orthotopic intracorporeal neobladder urinary diversion. This study describes the proposed advantages and  disadvantages of intracorporeal orthotopic neobladder urinary diversion and expert opinion on preference. Read More

View Article

Download full-text PDF

Source
April 2019
3 Reads

Intracorporeal neobladder.

Arch Esp Urol 2019 04;72(3):309-317

Hospital Universitario Puerta de Hierro. Madrid. Spain.

Objective: It is well known that RARC with intracorporeal diversion is being increasingly performed worldwide. In this article, we review the current situation of the intracorporeal neobladder.

Methods: We discuss the principles of intracorporeal orhotopic diversion, focusing on the most relevant: The Karolinska-modified Studer neobladder, the University of Southern California-modified Studer neobladder. Read More

View Article

Download full-text PDF

Source
April 2019
8 Reads

Robotic intracorporeal ileal conduit: Technical aspects.

Arch Esp Urol 2019 04;72(3):299-308

Catherine & Joseph Aresty Department of Urology. USC Institute of Urology and the Keck School of Medicine. University of Southern California. Los Angeles. CA. USA.

Objective: To present a review of the technical aspects of robotic intracorporeal ileal conduit  (IC) reconstruction after robot assisted radical cystectomy (RARC). METHODS: A non-systematic review is performed in order  to summarize technical aspects on robot assisted ileal conduit procedure following radical cystectomy in patients with muscle invasive bladder cancer.  RESULTS: Radical cystectomy with pelvic lymph node dissection and urinary diversion is the gold-standard therapy for localized muscle-invasive bladder cancer. Read More

View Article

Download full-text PDF

Source
April 2019
2 Reads

Robotic radical cystectomy.

Arch Esp Urol 2019 04;72(3):293-298

Department of Urology. Fundació Puigvert. Universitat Autonoma de Barcelona. Barcelona. Spain.

Objectives: Radical cystectomy (RC) is one of the most complex and morbid surgical procedures in Urology. Several retrospective and prospective studies have demonstrated that robotic-assisted RC (RARC) represents a minimally invasive alternative to open surgery, showing non-inferiority in mid-term oncological outcomes. Moreover, important advantages related with  perioperative complications have also been published. Read More

View Article

Download full-text PDF

Source

What's new in robotic partial nephrectomy.

Arch Esp Urol 2019 04;72(3):283-292

General Surgery and Urology. OLV Hospital. Belgium.

Objective: Robot assisted partial nephrectomy (RAPN) is a minimally invasive option for patients with small renal masses undergoing partial nephrectomy. In this review we provide an update on the oncological safety and renal functional outcomes following RAPN. We also discuss the novel techniques and technological advances that have contributed to the outcomes of RAPN. Read More

View Article

Download full-text PDF

Source
April 2019
4 Reads

Salvage robot-assisted radical prostatectomy following failed local treatments.

Arch Esp Urol 2019 04;72(3):277-282

Lyx Institute of Urology. Madrid. Spain. University Hospital Puerta de Hierro-Majadahonda. Madrid. Spain.

Prostate cancer represents the most commonly diagnosed cancer in men and is the second-leading cause of cancer related death in the United States. Primary treatment for prostate cancer includes radiotherapy or ablative procedures such as cryotherapy, and high-intensity focused ultrasound (HIFU). Unfortunately, a large proportion of these patients, especially with high risk features, may experience disease recurrence within 10 years. Read More

View Article

Download full-text PDF

Source
April 2019
2 Reads

Complications of robot assisted radical prostatectomy.

Arch Esp Urol 2019 04;72(3):266-276

Co-Head Robotic and Laparoscopic Surgery. Department of Urology. University Hospital La Zarzuela. Madrid. Spain.

The urology community has adopted robot-assisted radical prostatectomy (RARP) as the most preferred surgical therapeutic approach in the management of localized prostate cancer. Safety and potential complications of RARP should be clearly known prior to attempting the surgery. The complications have been categorized as anesthesia & patient positioning related, vascular, non-vascular and delayed. Read More

View Article

Download full-text PDF

Source
April 2019
2 Reads

Robot-assisted extended pelvic lymph node dissection in prostate cancer. When and how?

Arch Esp Urol 2019 04;72(3):257-265

Divisão de Urologia. Faculdade de Medicina da Universidade de São Paulo. Instituto do Câncer do Estado de São Paulo ICESP. São Paulo. Brazil.

Objective: To review the literature evaluating the role of the extended pelvic lymph node dissectione PLND during robot assisted radical prostatectomy (RARP) in the management of PCa patients, as well as the preoperative clinic pathologic factors that predict lymph node metastases (LNM). The technique and current outcomes of robotic ePLND will be presented.

Methods: Medline®/Pubmed® were searched up to august 2018 to find comparative studies of different anatomic limits of pelvic lymph node dissection (PLND) during RARP, open or pure laparoscopic surgery that reported number of nodes retrieved, oncologic outcomes and complications. Read More

View Article

Download full-text PDF

Source
April 2019
3 Reads

Technical features and the demonstrated advantages of the Retzius sparing robotic prostatectomy.

Arch Esp Urol 2019 04;72(3):247-256

Department of Urology. ASST Grande Ospedale Metropolitano Niguarda. Milan. Italy.

Objective: Robot-assisted laparoscopic  radical prostatectomy (RARP) is nowadays considered  the main surgical option for localized prostate cancer (PCa). We recently developed a new approach for RARP  avoiding all the Retzius structures involved in continence  and potency preservation, the so called Retzius-sparing  technique (RSP). The objective of the paper is to report technical aspects and functional results of RSP. Read More

View Article

Download full-text PDF

Source
April 2019
5 Reads

Robotic-assisted radical prostatectomy: The teaching.

Arch Esp Urol 2019 Apr;72(3):239-246

Departamento de Urología. L´Institute Mutualiste Montsouris. París. Francia.

Objective Of The Review: Robot assisted Radical prostatectomy (RARP) has generated a new trend in the binomial teaching/learning, grouping these techniques in training modules such as theoretical learning, practice, personalized counseling, and modern tools like simulation and practice in virtual models. This review summarizes the current trend in the teaching process of RARP. RECENT FINDINGS: Current trends in the acquisition of the RARP learning curve is to provide the Urologist with a well-structured teaching process, implementing gradual training modules, which make possible to understand all aspects of the development of prostate surgery with a robotic system. Read More

View Article

Download full-text PDF

Source

How to build a robotic program.

Arch Esp Urol 2019 04;72(3):227-238

Urología Clínica Bilbao SL. Clínica IMQ Zorrotzaurre. Bilbao. Bizkaia. España.

Objective: Advancements in the robotic surgical technology have revolutionized the standard of care for many surgical procedures. The purpose of this review is to focus on the different issues involved in developmental phase of starting a robotic program and to evaluate the important considerations in developing this program at a given healthcare institution.

Methods & Results: Although every hospital might desire a robotic program, there are many requirements needed to uphold a successful and self-sustainable program in the current healthcare market. Read More

View Article

Download full-text PDF

Source
April 2019
4 Reads

Current status of robotic surgery in urology.

Arch Esp Urol 2019 04;72(3):225-226

Servicio de Urología. Hospital Universitario Rey Juan Carlos. Móstoles. Madrid. Spain.

A few decades ago, minimal invasive  surgery changed the way we understand and perform surgery. Before the revolution of minimal invasive techniques, we accepted and justified a certain degree of trauma on the tissues in order to provide benefit and healing  to the patient. With the adoption of new technologies, we realized that we could achieve the same or even better results with fewer side  effects. Read More

View Article

Download full-text PDF

Source
April 2019
4 Reads

Inmunotherapy in prostate cancer.

Arch Esp Urol 2019 Mar;72(2):211-222

Department of Urology. Eberhard Karls University Tübingen. Germany.

Prostate cancer (PCa) is the second most commonly diagnosed cancer. Although systemic chemotherapeutic agents, such as cabazitaxel, abiraterone and enzalutamde have become available to patients over the last decade, metastatic PCa is still an incurable disease. Immunotherapy is showing great promise in a wide range of other cancer types. Read More

View Article

Download full-text PDF

Source
March 2019
4 Reads

High-risk prostate cancer. Optimal treatment. New evidences.

Arch Esp Urol 2019 Mar;72(2):203-210

Department of Urology. Hospital Universitario La Paz. Madrid. Spain. Instituto de Investigación Hospital Universitario La Paz (IdiPAZ). Madrid. Spain. Universidad Autónoma de Madrid. Madrid. Spain.

There are multiple definitions of high risk prostate cancer and each definition is associated with a different prognosis. Men classified as having high-risk disease warrant treatment because durable outcomes can be achieved. Radical prostatectomy, radiation therapy and androgen deprivation therapy play pivotal roles in the management of men with high-risk disease, and potentially in men with metastatic disease. Read More

View Article

Download full-text PDF

Source
March 2019
6 Reads

Hormone naïve metastatic prostate cancer: How to treat it?

Arch Esp Urol 2019 Mar;72(2):192-202

Department of Urology. Herlev and Gentofte Hospital. Herlev. Denmark.

Objectives: Recent landmark studies (GETUG-AFU 15, CHAARTED, STAMPEDE (docetaxel), LATITUDE and STAMPEDE (abiraterone)) have changed the treatment of hormone sensitive metastatic prostate cancer (mHSPC) from androgen deprivation therapy (ADT) only to combined therapy with either docetaxelor abiraterone acetate plus prednisone (AAP) together with ADT. In this Review we highlight current evidence and recommendations on how to treat men with newly diagnosed mHSPC beyond ADT. METHODS: Narrative overview of available evidence retrieved from pubmed searches, hand searches and authoritative texts. Read More

View Article

Download full-text PDF

Source
March 2019
6 Reads

Management of positive lymph nodes following radical prostatectomy.

Arch Esp Urol 2019 Mar;72(2):182-191

Department of Urology and Robot-assisted and Reconstructive Surgical Urology. University of Cologne. Cologne. Germany.

Oligometastatic prostate cancer (PCA) has increasingly been detected in the era of modern imaging studies such as choline-specific and prostate-specific membrane antigen (PSMA)-positron emission tomography and X-ray computed tomography (PET/CT). Recent evidence suggests that durable control is attainable with local treatment modalities such as salvage metastasectomy or stereotactic radiation therapy targeting oligometastases, either with or without the use of systemic therapy.The purpose of this article is to critically review the current findings on the indication, extent, and oncologic outcome of salvage lymphadenectomy (SLND). Read More

View Article

Download full-text PDF

Source
March 2019
2 Reads

Current concepts in oligometastatic prostate cancer: Is there a role for radical prostatectomy?

Arch Esp Urol 2019 Mar;72(2):174-181

University College London Hospital. NHS Foundation Trust. London. UK. Nuffield Department of Surgical Sciences. University of Oxford. Oxford. UK.

Introduction: Prostate cancer is the most common solid organ malignancy in men. Despite the implementation of PSA screening, the incidence of metastatic prostate cancer in Spain is still around 4%. In this clinical scenario, systemic treatment is the gold standard. Read More

View Article

Download full-text PDF

Source

Future of focal therapy for the treatment of prostate cancer- european section of urotechnology (ESUT) position.

Arch Esp Urol 2019 Mar;72(2):167-173

Department of Urology. La Paz University Hospital. Madrid. Spain. Instituto de Investigación Hospital Universitario La Paz (IdiPAZ). Madrid. Spain.

Introduction: Focal therapy (FT) is a treatment option for prostate cancer (PCa), which offers the possibility of an effective therapy in selected patients who have the localized disease, with a significant reduction in treatment related morbidity. Based on the current status of FT, our objective was to determine the most appropriate strategy to improve patient management.

Materials And Methods: A literature review was done performed through the PubMed database and focused on the following topics: localised prostate cancer,MRI, prostate biopsies, ablative therapy and focal therapy. Read More

View Article

Download full-text PDF

Source

Active surveillance in intermediate risk prostate cancer.

Arch Esp Urol 2019 Mar;72(2):157-166

Division of Urology. Sunnybrook Health Sciences Centre. Toronto. ON. Canada.

Objectives: Active Surveillance (AS) has become an established treatment option for men with low-risk prostate cancer (PCa), demonstrating superior functional outcomes and excellent oncologic outcomes.As such, it has been appealing to extend AS to patients with intermediate risk PCa. We provide a review of the current experience with AS in the intermediate-risk PCa population. Read More

View Article

Download full-text PDF

Source
March 2019
2 Reads

The future of molecular and functional imaging in prostate cancer.

Arch Esp Urol 2019 Mar;72(2):150-156

Médecine Nucléaire. Hôpital Tenon AP-HP. Institut Universitaire de Cancérologie. Health Economics Research Unit - APHP. INSERM UMR 1123Sorbonne Universités. Paris. France.

The major goal of prostate cancer imaging in the next decade will be more accurate disease diagnostic, characterization and staging through the synthesisof anatomic, functional and molecular imaging.Changes are happening regarding the use of prostate MRI for evaluating primary prostate cancer and PET CT for the staging and recurrence staging of prostate cancer.This review presents a multidisciplinary perspective of the role of prostate MRI and molecular imaging in prostate cancer. Read More

View Article

Download full-text PDF

Source

New standards in prostate biopsy.

Arch Esp Urol 2019 Mar;72(2):142-149

Department of Urology. University College London Hospitals NHS Foundation Trust. London. UK. Division of Surgery & Interventional Science. University College London. UK.

Objectives: Prostate cancer diagnosis is undergoing a significant change in recent years. The concern about prostate cancer overtreatment as well astechnological developments that allow for better visualization of prostate cancer lesions are the main drivers for this change.

Methods: This was a narrative review of the literature on prostate cancer diagnosis. Read More

View Article

Download full-text PDF

Source
March 2019
3 Reads

Magnetic resonance imaging and prostate cancer: Perspectives from the UK, Europe and USA.

Arch Esp Urol 2019 Mar;72(2):135-141

Division of Surgery & Interventional Science. University College London. London. UK. Department of Urology. University College London Hospital NHS. Foundation Trust, London. UK.

There is yet no international consensus on the role of multiparametric magnetic resonance imaging (mpMRI) for prostate cancer diagnosis, with different uses in different health care systems around the world. In this report we will discuss the use of mpMRI in the United Kingdom, Europe and in the United States of America, comparing the most important guidelines and major papers over the last few years. Read More

View Article

Download full-text PDF

Source

New markers in prostate cancer: Inmunohistochemical.

Authors:
Eva Compérat

Arch Esp Urol 2019 Mar;72(2):126-134

Sorbonne University. Hôpital Tenon. Paris. France.

Although pathology is the gold standard for confirming the diagnosis of prostate cancer (PCa), several marker for diagnosis may be useful and will helpin doubtful cases to confirm the diagnosis of PCa. Therfore it is important to spread the knowledge of immunomarker, in order to improve the clinicians understanding of stains and their usefulness. Like in other organs, clinicians and pathologists would like not to rely only on pathological criteria such as PSA, Gleason score, tumor size and pT stage, but also on tumor stains, permitting to predict prognosis and patients outcome, especially in patients with intermediate risk. Read More

View Article

Download full-text PDF

Source
March 2019
6 Reads

New markers in prostate cancer: Genomics.

Arch Esp Urol 2019 Mar;72(2):116-125

Department of Urology. University Hospital and Faculty of Medicine. Technische Universität Dresden. Dresden. Germany. National Center for Tumor Diseases (NCT), partner site Dresden. Dresden. Germany.

Prostate cancer (PCa) is a very heterogeneous disease with unknown outcome at the time of first diagnosis. Multiple clinicopathological parameters andmodern imaging approaches are currently used to detect PCa and to assess the necessity of early or delayed treatment according to the predicted aggressiveness of the tumor. Despite regular adjustments of predictive systems based on histopathological factors such as the Gleason grading system or based on prostate MRI such as the Prostate Imaging Reporting and Data System (PIRADS) these tools for risk stratification of PCa patients still harbor significant limitations with regard to the accuracy of PCa outcome prediction. Read More

View Article

Download full-text PDF

Source
March 2019
1 Read

Biomarkers in prostate cancer management. Is there something new?

Arch Esp Urol 2019 Mar;72(2):105-115

Department of Urology. Hospital Universitario La Paz. Madrid. Spain. Universidad Autónoma de Madrid. Madrid. Spain. Instituto de investigación Hospital Universitario La Paz (IdiPAZ). Madrid. Spain.

Introduction: Prostate cancer (PCa) diagnosis cornerstone has been prostate-specific antigen levels during the past decades, with a worrisome overdiagnosis and overtreatment of non-clinically significant disease. These pitfalls have prompted the search for more accurate molecular and genetic tests such asgenetic biomarkers. These new assays allow the testing of serum, urine, or prostatic tissue for molecular and genetic signs of prostate cancer, and provide information regarding both diagnosis and prognosis. Read More

View Article

Download full-text PDF

Source

Screening: Actual trends on PSA marker. When, who, how?

Arch Esp Urol 2019 Mar;72(2):98-103

Department of Urology. L'Institut Mutualiste Montsouris. Université Paris Descartes. Paris. France.

Prostate cancer (PCa) is the most common non-skin malignancy among men world-wide. PCa incidence is higher among African American (AA) menin comparison to the white population. Men with a previous history of PCa in first-line relatives carry also an increased risk for this disease. Read More

View Article

Download full-text PDF

Source
March 2019
6 Reads

New paradigms in prostate cancer.

Arch Esp Urol 2019 Mar;72(2):95-97

Department of Urology. Hospital Universitario La Paz. Madrid. Spain.

Prostate cancer remains the most common malignancy diagnosed in men andis the third leading cause of cancer death among men in the United States and Europe.On this basis, it is anticipated by many that the rates of prostate cancer mortality may rise in the years to come. As a result, a number of new challenges have emerged in prostate cancer, forcing urologists to consider new paradigms in the disease management: both to improve methods of detection and to be more effective in managing the likely increasing numbers of men with advanced disease. Read More

View Article

Download full-text PDF

Source
March 2019
1 Read

Post void incontinence secondary to female urethral diverticulum.

Arch Esp Urol 2019 Jan;72(1):91-92

Hospital Universitario de Fuenlabrada. Madrid. España.

A 38 year old woman with nopast medical or surgical history of interest,derived by occasional dysuria and post voidincontinence by her family doctor, with negativeurine culture... Read More

View Article

Download full-text PDF

Source
January 2019
2 Reads

Bladder cancer with Indian ink.

Arch Esp Urol 2019 Jan;72(1):89-90

Hospital Clínico Universitario Lozano Blesa. Zaragoza. España.

72 year old female with a historyof breast cancer in remission, under study formonosymptomatic haematuria. Cystoscopy studyshows pigmented mucosal areas.. Read More

View Article

Download full-text PDF

Source
January 2019
5 Reads

[Report of two cases of malignant mesothelioma of the tunica vaginalis.]

Arch Esp Urol 2019 Jan;72(1):85-88

Servicio de Urología. Hospital General Universitario de Valencia. Valencia. España.

Objective: Paratesticular mesothelioma isan infrequent tumor and only 250 cases have been published.It originates in the scrotal tunica vaginalis. It represents0. Read More

View Article

Download full-text PDF

Source
January 2019
3 Reads

[Renal cell carcinoma metastases in rare anatomical locations: pituitary, thyroid and mammary glands. of our experience and report of three cases.]

Arch Esp Urol 2019 Jan;72(1):80-84

Servicio de Urología. Hospital de Cabuenes. Gijón. Asturias. España.

Objective: Metastatic Renal Cell Carcinoma(RCC) may develop in different anatomical locationsand after a strict follow up within normal limits. We assessthe importance of close follow up in patients with historyof RCC through 3 clinical cases with unusual locations ofmetastatic RCC.

Methods: We present 3 cases of metastatic involvementof pituitary, thyroid and mammary glands. Read More

View Article

Download full-text PDF

Source
January 2019
13 Reads

Colonizations on biofilm layers of D-J catheters under sterile urine conditions.

Arch Esp Urol 2019 Jan;72(1):75-79

Department of Urology. University of Gaziantep. Gaziantep. Turkey.

Objective: To evaluate colonizations onbiofilm layers of Double J (D-J) catheters implanted forkidney stones or ureteral stones under sterile conditions.

Methods: D-J catheters implanted between January2012 and February 2014 and removed in 0-90 days,were examined in microbiology laboratory prospectively.Fifty two patients divided into three groups regardingthe duration of the D-J catheters as; 0-30 days, 31-60days, 61-90 days. Read More

View Article

Download full-text PDF

Source
January 2019
17 Reads

The effect of additional telerounding on postoperative outcomes, patient and surgeon satisfaction rates in the patients who underwent percutaneous nephrolithotomy.

Arch Esp Urol 2019 Jan;72(1):69-74

Department of Urology. Izmir Bozyaka Training and Research Hospital. Izmir. Turkey.

Introduction: We wanted to investigate the potential effect of additional telerounding system on postoperative outcomes, patient and surgeon satisfaction rates in the patients who underwent percutaneous nephrolithotomy (PNL).

Methods: Eighty patients who underwent PNL were included in the study. The patients were randomly divided to two groups. Read More

View Article

Download full-text PDF

Source
January 2019

Results of minimally invasive procedures for ESWL refractory renal stones smaller than 2 cm: A single center experience.

Arch Esp Urol 2019 Jan;72(1):61-68

Department of Urology . Gaziantep University. Gaziantep. Turkey.

Objectives: To evaluate the efficacyand reliability of endourological procedures in patientswith renal stones up to 2 cm that were found to be resistantto extracorporeal shock wave lithotripsy (ESWL).

Methods: 611 patients who had undergone ESWLdue to renal stones up to 2 cm at the ESWL unit of ourclinic, were retrospectively evaluated. Standard percutaneousnephrolithotomy (PNL), micro-PNL, retrogradeintrarenal surgery (RIRS) was performed on the patientswho had stones resistant to ESWL. Read More

View Article

Download full-text PDF

Source
January 2019

Retrograde intrarenal surgery or percutaneous nephrolithotomy: Which one is more effective for 1-2 cm renal stones in pediatric patients?

Arch Esp Urol 2019 Jan;72(1):54-60

Kecioren Research and Training Hospital. Department of Urology. Ankara. Turkey.

Introduction: Urinary stone diseaseis less common in pediatric age group and it has anincreasing incidence. In this study, our hypothesis is toevaluate if one of the techniques, PNL or RIRS is superiorthan the other in terms of stone free status (SFR), fluoroscopytime (FT), operation time (OT), complication rate(CR), JJ stent insertion rate, and hospitalization duration(HD) in children.

Methods: Between 2013 and 2016, 74 patients(under 18 years- old) were operated for the treatmentof renal stones between 1-2cm size. Read More

View Article

Download full-text PDF

Source
January 2019
2 Reads

[Analisys of non-neurogenic lower urinary tract dysfunction patterns controlled in a Pediatric urodynamic unit.]

Arch Esp Urol 2019 Jan;72(1):45-53

Hospital Materno Infantil Teresa Herrera. A Coruña. España.

Objectives: Between 7-10% of schoolagechildren are seen by specialists for non-neurogeniclower urinary tract dysfunction (LUTD). The objective ofour study is to classify these functional alterations in difused for the diagnosis and treatment in each pattern.

Material And Methods: We reviewed patients referredto our Urodynamic Unit for suspected LUTD for3 years; We reviewed epidemiological data, supplementarytest and treatments. Read More

View Article

Download full-text PDF

Source
January 2019
3 Reads

[Clinical usefulness of the non-invasive functional study of the lower urinary tract voiding phase as a predictor of resolution after the first endoscopic treatment of vesico-ureteral reflux in children older than 3 years.]

Arch Esp Urol 2019 Jan;72(1):36-44

Sección de Urología Infantil. Servicio de Urología. Hospital Universitari i Politècnic La Fe. Valencia. España.

Objectives: To determine the usefulnessof voiding diary (VD), uroflowmetry with electromyography(UF-EMG), bladder wall thickness (before micturition)(VWTUS) and residual urine (PVR) (ultrasound measure)in predicting the outcome of the first endoscopic treatment(1ENDT) of vesicoureteral reflux (VUR) in children> 3 years.

Methods: Cross-sectional ambispective study of 48children with vesicoureteral reflux. Those with previousendoscopic treatment, age or neurological abnormalities and a history of urethralor abdominal surgery were excluded. Read More

View Article

Download full-text PDF

Source
January 2019
2 Reads

[Design and validation of a satisfaction questionnaire in patients with urolithiasis treated by extracorporeal shock wave lithotripsy (ESWL).]

Arch Esp Urol 2019 Jan;72(1):25-35

Departamento de Urología. Clínica Universidad de Navarra. Pamplona. España.

Objectives: Studying the psychosocial sphere of patients who undergo any treatment allows to have more information about its repercussion and can help the choice of an appropriate and personalized treatment. Due to the absence of specific instruments at present, the objective is to design and validate a health questionnaire regarding the treatment received with ESWL.

Methods: It was carried out in 6 phases using a sampleof 50 patients treated with ESWL in 2015 in ourcenter, whom we interviewed by telephone. Read More

View Article

Download full-text PDF

Source
January 2019
1 Read

[Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy.]

Arch Esp Urol 2019 Jan;72(1):16-24

Servicio de Urología. Hospital de Carabineros de Chile. Santiago. Chile.

Introduction: The limitations of serumPSA as a screening test to detect prostate cancer remainproblematic, especially after an initial negative prostatebiopsy. Detection of primary circulating prostate cells(CPCs) has been reported to be useful in the detectionof prostate cancer in men with a serum PSA>4.0ng/ml. Read More

View Article

Download full-text PDF

Source
January 2019
9 Reads

[Prostate cancer is associated with the anogenital distance, a biomarker of prenatal androgen milieu.]

Arch Esp Urol 2019 Jan;72(1):9-15

Departamento de Ciencias Sociosanitarias. Área de Medicina Preventiva y Salud Pública. Facultad de Medicina. Universidad de Murcia. Murcia. España. Grupo de Metodología de Investigación en Ciencias de la Salud. Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca). Murcia. España. CIBER Epidemiología y Salud Pública (CIBERESP). Madrid. España. Servicio de Medicina Preventiva. Hospital Clínico Universi.

Objective: To evaluate the associationbetween anogenital distance (AGD), as a biomarker ofprenatal androgen milieu, and risk of prostate cancer(PCa).

Methods: A case-control study was conducted on260 men attending a university hospital where theyunderwent physical and andrological examination andcompleted a brief questionnaire. PCa patients were confirmedby biopsy of the tumor. Read More

View Article

Download full-text PDF

Source
January 2019
2 Reads

[Usefulness of photodynamic diagnosis in high-grade Bladder Cancer and subsequent BCG failure. Bibliographic review.]

Arch Esp Urol 2019 Jan;72(1):2-8

Servicio de Urología. Institut Mutualiste Montsouris. París. Francia.

Objectives: Bladder tumors are thesecond highest incidence urological tumor in the adultpopulation. In recent years, new techniques such as photodynamicdiagnosis have arisen in order to improvethe sensitivity for the detection of non muscle invasivebladder cancer (NMIBC). We intend to update the roleof photodynamic diagnosis in the diagnosis of NMIBC,in cases refractory to BCG and as a treatment in therecurrent bladder cancer. Read More

View Article

Download full-text PDF

Source
January 2019

[Antibiotic prophylaxis for flexible cystoscopy. Perspectives for Latin America and Caribbean.]

Arch Esp Urol 2019 Jan;72(1)

Clínica de Urología Avanzada UROZEN Lima. Lima. Perú.

Sr. Editor: Los resultados de Cano-García et al. (1) en el último estudio publicado sobre la profilaxis antibiótica con ciprofloxacino en uretrocistoscopia flexible (UF) son claros y fuertes, si bien la pregunta clínica pudo ser respondida mediante un estudio de intervención (ensayo clínico), el diseño utilizado es bueno y aproximado pero difiriendo de algunos puntos claves: aleatorización, denominación de grupo control y asignación del tratamiento. Read More

View Article

Download full-text PDF

Source
January 2019

Vitamin D deficiency in infertile patients.

Arch Esp Urol 2018 Dec;71(10):850-855

Department of Urology. Ataturk University Medical Faculty. Erzurum. Turkey.

Objectives: According to the WorldHealth Organization (WHO) definition, infertility is "thefailure of a sexually active, non-contracepting couple toachieve pregnancy in one year" and is a complicateddisorder with its medical, psychosocial and economicaspects. There is some proof that vitamin D deficiencyhas important effects on the male reproductive system.There are numerous animal trials and a limited numberof human trials investigating this topic. Read More

View Article

Download full-text PDF

Source
December 2018
7 Reads

Skin metastasis of prostate cancer. An unusual entity.

Arch Esp Urol 2018 Dec;71(10):869-870

Servicio de Urología. Complejo Asistencial de Salamanca. Salamanca. España.

Male, 64 year old male, whoconsults to the Dermatology office presentingtwo-month, progressive, skin lesions in thepubic region... Read More

View Article

Download full-text PDF

Source
December 2018
1 Read

Three pelvic fused kidneys.

Arch Esp Urol 2018 Dec;71(10):867-868

UGC Urología. Hospital La Inmaculada. Huercal-Overa. Almeria. España.

Pelvic renal ectopia is a rare anatomical abnormality that can present in different forms andlocations (1)... Read More

View Article

Download full-text PDF

Source
December 2018
1 Read

Urinary bladder xanthoma: Two case reports and a review of the literature.

Arch Esp Urol 2018 Dec;71(10):862-866

Department of Pathology. Policlinico San Martino Hospital. University of Genova. Genova. Italy.

Objective: We present two rare cases ofbladder xanthomata associated with transitional cell carcinoma.

Method And Results: Cases description and selectionof related pictures. Review of the existing literature. Read More

View Article

Download full-text PDF

Source
December 2018
1 Read

Eosinophilic cystitis treated with hydrodistention and complementary methods: Case report.

Arch Esp Urol 2018 Dec;71(10):859-862

Clinica de Urología Avanzada UROZEN. Lima. Perú.

Objective: Even though there is no established standard therapy for Eosinophilic cystitis (EC), the series of cases guide us in the treatment of patients. We report our therapeutic experience with hydrodistention and complementary methods. In order to establish a standard treatment in patients with EC. Read More

View Article

Download full-text PDF

Source
December 2018
11 Reads